The Hippo signaling pathway: a potential therapeutic target is reversed by a Chinese patent drug in rats with diabetic retinopathy

• Egile Nagusiak: Gai-mei Hao (Egilea), Tian-tian Lv (Egilea), Yan Wu (Egilea), Hong-liang Wang (Egilea), Wei Xing (Egilea), Yong Wang (Egilea), Chun Li (Egilea), Zi-jian Zhang (Egilea), Zheng-lin Wang (Egilea), Wei Wang (Egilea), Jing Han (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2017-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background The Hippo signaling pathway is reported to be involved in angiogenesis, but the roles of the Hippo pathway in diabetic retinopathy have not been addressed. Fufang Xueshuantong Capsule has been used to treat diabetic retinopathy in China; however, the effect of Fufang Xueshuantong...